Severe dual fungal infection after bispecific antibody therapy: A case of invasive aspergillosis and mucormycosis in immunocompromised patient

Severe dual fungal infection after bispecific antibody therapy: A case of invasive aspergillosis and mucormycosis in immunocompromised patient

Bispecific antibody is a new treatment for hematological disease, especially for lymphoma, myeloma and acute lymphoblastic leukemia. This class of treatment presents the same kind of side effect as CAR-T cell which are immune-mediated. Nevertheless, infectious complication remains a major concerns w...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarah Sakalihasan, Frédéric Lifrange, Mathieu Czajkowski, Veronique Goncette, Bernard Duysinx, Pierre Lovinfosse, Damla Can, Raphael Schils, Marie-Pierre Hayette, Adrien De Voeght
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:IDCases
Subjects:
Case report
Mycotic bi-therapy
Aerosol
Immunocompromised patient
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250924002166
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items